Novavax on Thursday posted a narrower fourth-quarter loss and said it expects its licensing deal with French drugmaker Sanofi ...

House Republicans are urging President Trump to use executive action on COVID-19 mandates for organ transplants.

Novavax's fourth-quarter loss narrowed on Thursday, helped by reduced selling and administrative expenses of COVID-19 ...

The current COVID-19 vaccine is 33% effective at preventing emergency department or urgent care visits among adults of all ages. It also is 45% to 46% effective at preventing hospitalizations in older ...

Cornell researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both ...

A bill banning gene-based vaccines, like some forms of the COVID-19 vaccine, received approval from a Senate subcommittee ...

Children vaccinated against COVID-19 were more than 50% less likely to develop at least one long COVID symptom compared with ...

The new vaccine addresses significant limitations of existing COVID-19 and flu vaccines. While mRNA COVID-19 vaccines require ...

Yale researchers have found clues as to why certain people experience adverse health effects after the COVID-19 vaccine, ...

In a small study, Yale researchers have found "differences in immune profiles" among those who have rare reaction to the ...

Arbutus Biopharma and Genevant Sciences are broadening the scope of their patent infringement claims against Moderna with ...

Iowa lawmakers are proposing a bill that could make it harder for Iowans to get a COVID-19 vaccine. I'm southwest Iowa ...